Multiple Sclerosis Data Alliance - A global multi-stakeholder collaboration to scale-up real world data research

被引：13

作者：

Peeters, Liesbet M. ^{[1
,2
]}

Parciak, Tina ^{[3
]}

Kalra, Dipak ^{[4
]}

Moreau, Yves ^{[5
]}

Kasilingam, Elisabeth ^{[6
]}

van Galen, Pieter ^{[6
]}

Thalheim, Christoph ^{[6
]}

Uitdehaag, Bernard ^{[7
]}

Vermersch, Patrick ^{[8
]}

Hellings, Niels ^{[1
]}

Stinissen, Piet ^{[1
]}

Van Wijmeersch, Bart ^{[1
]}

Ardeshirdavani, Amin ^{[5
]}

Pirmani, Ashkan ^{[1
,2
,5
]}

De Brouwer, Edward ^{[5
]}

Bauer, Christian Robert ^{[3
]}

Krefting, Dagmar ^{[3
,9
]}

Ribbe, Stephanie ^{[10
]}

Middleton, Rod ^{[11
]}

Stahmann, Alexander ^{[12
]}

Comi, Giancarlo ^{[13
]}

机构：

[1] Hasselt Univ, Univ MS Ctr, Biomed Res Inst BIOMED, Agoralaan Bldg C, B-3590 Diepenbeek, Belgium

[2] Hasselt Univ, Data Sci Inst DSI, Agoralaan Bldg D, B-3590 Diepenbeek, Belgium

[3] Univ Med Ctr Gottingen, Dept Med Informat, Von Siebold Str 3, D-37075 Gottingen, Germany

[4] Univ Ghent, Unit Med Informat & Stat, B-9000 Ghent, Belgium

[5] KULeuven, Dept Elect Engn ESAT STADIUS, Kasteelpk Arenberg 10, B-3001 Leuven, Belgium

[6] European Multiple Sclerosis Platform, Rue A Lambiotte, B-1030 Brussels, Belgium

[7] Vrije Univ Amsterdam, Amsterdam UMC, Dept Neurol, MS Ctr Amsterdam,Amsterdam Neurosci, POB 7057, NL-1007 MB Amsterdam, Netherlands

[8] Univ Lille, CHU Lille, LIRIC INSERM U995, Lille, France

[9] Univ Appl Sci Berlin, Berlin, Germany

[10] Novartis Int AG Forum 1, Novartis Campus, CH-4056 Basel, Switzerland

[11] Swansea Univ, DSB, UK MS Register, Singleton Pk, Swansea, W Glam, Wales

[12] MS Forsch & Projektentwicklungs gGmbH, German MS Register, Krausenstr 50, D-30171 Hannover, Germany

[13] Osped San Raffaele, Inst Expt Neurol, Via Olgettina 48, I-20132 Milan, Italy

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2021年 / 47卷

关键词：

Real world data; multiple sclerosis; learning health system; collaboration; patient engagement; EUROPE;

D O I：

10.1016/j.msard.2020.102634

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The Multiple Sclerosis Data Alliance (MSDA), a global multi-stakeholder collaboration, is working to accelerate research insights for innovative care and treatment for people with multiple sclerosis (MS) through better use of real-world data (RWD). Despite the increasing reliance on RWD, challenges and limitations complicate the generation, collection, and use of these data. MSDA aims to tackle sociological and technical challenges arising with scaling up RWD, specifically focused on MS data. MSDA envisions a patient-centred data ecosystem in which all stakeholders contribute and use big data to co-create the innovations needed to advance timely treatment and care of people with MS.

引用

页数：4

共 50 条

[21] A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data for patients with metastatic lung cancer.
Lu, Michael W.
Walia, Guneet
Schulze, Katja
Doral, Michelle Yuri
Maund, Sophia L.
Gaffey, Sarah
Cabili, Moran N.
Bourla, Ariel B.
Green, Robert J.
Santos, Eric C.
Herbst, Roy S.
Chiang, Anne C.
Schwartzberg, Lee S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[22] Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project
Celani, Maria Grazia
Nonino, Francesco
Mahan, Kathryn
Orso, Massimiliano
Ridley, Ben
Baldin, Elisa
Bignamini, Angelo Antonio
D'Amico, Roberto
Cantisani, Teresa Anna
Colombo, Cinzia
Khan, Fary
Koepke, Sascha
Laurson-Doube, Joanna
Schvarz, Catherine
Young, Carolyn A.
Peryer, Guy
Rosati, Paolo
Filippini, Graziella
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
[23] Overview of global real-world data sources for pediatric pharmacoepidemiologic research
Wharton, Gerold T.
Becker, Claudia
Bennett, Dimitri
Burcu, Mehmet
Bushnell, Greta
Ferrajolo, Carmen
Kaplan, Sigal
Mcmahon, Ann W.
Movva, Naimisha
Raman, Sudha R.
Scholle, Oliver
Suh, Mina
Sun, Jenny W.
Horton, Daniel B.
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
[24] ECONOMIC IMPACT OF INNOVATIVE DRUGS FOR MULTIPLE SCLEROSIS: A REAL-WORLD DATA ANALYSIS
Buigues-Pastor, L.
Uso-Talamantes, R.
Alos-Alminana, M.
[J]. VALUE IN HEALTH, 2022, 25 (01) : S259 - S259
[25] Multiple sclerosis patients initiating ofatumumab in the real-world: 6 months data
Coyle, P.
Gorritz, M.
Wade, R.
Zhou, Z.
Cao, Y.
Deshpande, C.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 715 - 716
[26] A Multicenter Real-World Data of Cladribine Tablets in Patients with Multiple Sclerosis in Turkey
Koseoglu, Mesrure
Omerhoca, Sami
Balci, Fatma Belgin
Unal, Aysun
Ozdemir, Zeynep
Yuksel, Burcu
Celik, Rabia Gokcen Gozubatik
Toprak, Ufuk Emre
Gursoy, Esra Azize
Icen, Nilufer Kale
Altunrende, Burcu
[J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1017 - 1017
[27] Real-World Lab Data in Natalizumab Treated Multiple Sclerosis Patients Up to 6 Years Long-Term Follow Up
Kaufmann, Maxi
Haase, Rocco
Proschmann, Undine
Ziemssen, Tjalf
Akguen, Kafja
[J]. FRONTIERS IN NEUROLOGY, 2018, 9
[28] Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: Recommendations from a global task force
Parciak, Tina
Geys, Lotte
Helme, Anne
van der Mei, Ingrid
Hillert, Jan
Schmidt, Hollie
Salter, Amber
Zakaria, Magd
Middleton, Rodden
Stahmann, Alexander
Dobay, Pamela
Hernandez Martinez-Lapiscina, Elena
Iaffaldano, Pietro
Plueschke, Kelly
Rojas, Juan, I
Sabido, Meritxell
Magyari, Melinda
van der Walt, Anneke
Arickx, Francis
Comi, Giancarlo
Peeters, Liesbet M.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 396 - 418
[29] Real-world public health interventions demonstrate how research evidence informs program scale-up
Crane, Melanie
Lee, Karen
Wolfenden, Luke
Phongsavan, Philayrath
Bauman, Adrian
[J]. HEALTH PROMOTION INTERNATIONAL, 2024, 39 (05)
[30] Impact of informative follow-up visits on comparative effectiveness in multiple sclerosis: illustrations and insights from real world data
Saha-Chaudhuri, P.
Liao, S.
Simoneau, G.
Pellegrini, F.
de Moor, C.
Belachew, S.
Shen, C.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 708 - 708

← 1 2 3 4 5 →